COST-EFFECTIVENESS ANALYSIS OF LURASIDONE AND OLANZAPINE IN THE TREATMENT OF SCHIZOPHRENIA

被引：0
|
作者：
Priyadarshini, M. [1 ]
Hay, J. W. [1 ]
机构：
[1] Univ Southern Calif, Los Angeles, CA USA
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.1380
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMH40
引用
收藏
页码：A188 / A189
页数：2
相关论文
共 50 条
  • [1] VALIDATING A COST-EFFECTIVENESS ANALYSIS COMPARING OLANZAPINE WITH ZIPRASIDONE IN THE TREATMENT OF SCHIZOPHRENIA
    Graham, C.
    Mauskopf, J.
    Lawson, A. H.
    Ascher-Svanum, H.
    Bruhn, D.
    Watson, P. R.
    VALUE IN HEALTH, 2010, 13 (03) : A113 - A113
  • [2] Cost-effectiveness of olanzapine vs. aripiprazole in the treatment of schizophrenia
    Ascher-Svanum, Haya
    Stensland, Michael D.
    Peng, Xiaomei
    Faries, Douglas E.
    Stauffer, Virginia L.
    Osuntokun, Olawale O.
    Kane, John M.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (01) : 115 - 122
  • [3] A cost-effectiveness comparison of olanzapine and risperidone in the treatment of schizophrenia in Italy
    Beard, S
    Lothgren, M
    Giudi, L
    Ramacciotti, F
    Nardini, M
    Berardi, D
    VALUE IN HEALTH, 2002, 5 (06) : 515 - 515
  • [4] Comparative cost-effectiveness of amisulpride and olanzapine in the treatment of schizophrenia in China
    Yi, Zhan-Miao
    Men, Peng
    Qu, Shuli
    Li, Chaoyun
    Yu, Xin
    Zhai, Suodi
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2020, 20 (03) : 313 - 320
  • [5] COST-EFFECTIVENESS ANALYSIS OF AMISULPRIDE AND OLANZAPINE FOR PATIENTS WITH SCHIZOPHRENIA IN CHINA
    Men, P.
    Yi, Z.
    Li, C.
    Qu, S.
    Xiong, T.
    Yu, X.
    Zhai, S.
    VALUE IN HEALTH, 2018, 21 : S185 - S185
  • [6] Decision analysis model evaluating the cost-effectiveness of risperidone, olanzapine and haloperidol in the treatment of schizophrenia
    Bounthavong, Mark
    Okamoto, Mark P.
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2007, 13 (03) : 453 - 460
  • [7] A COST-EFFECTIVENESS ANALYSIS OF PALIPERIDONE PALMITATE VERSUS OLANZAPINE PAMOATE IN THE TREATMENT OF SCHIZOPHRENIA IN NORWAY
    Einarson, T. R.
    Vicente, C.
    Zilbershtein, R.
    Piwko, C.
    VALUE IN HEALTH, 2011, 14 (07) : A292 - A293
  • [8] Cost-effectiveness of amisulprid compared to risperidone and olanzapine in the treatment of schizophrenia in Poland
    Kowalik, E.
    Jakubczyk, M.
    Lis, J.
    Niewada, M.
    VALUE IN HEALTH, 2006, 9 (06) : A314 - A314
  • [9] Cost-effectiveness of orally dissolving olanzapine tablets in the treatment of schizophrenia in the USA
    Ascher-Svanum, H.
    Furiak, N. M.
    Klein, R. W.
    Smolen, L. J.
    Watson, P. R.
    Lawson, A. H.
    VALUE IN HEALTH, 2008, 11 (03) : A119 - A119
  • [10] COST-EFFECTIVENESS OF OLANZAPINE IN THE FIRST-LINE TREATMENT OF SCHIZOPHRENIA IN CHINA
    Zhao, J.
    Jiang, K.
    Li, Q.
    Zhang, Y. L.
    Cheng, Y.
    Lin, Z.
    Xuan, J.
    VALUE IN HEALTH, 2018, 21 : S76 - S77
12345